BIOR - Biora Therapeutics Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: Other OTC Current Price & Safety Score Price: 0.22 USD StockBonds Safety Grade: Altman Z-Score (Bankruptcy Risk): -100.00 StockBond Score: -2.96 Company Description Biora Therapeutics Inc a biotechnology company engages in developing oral biotherapeutics The companys targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal GI tract to enhance the treatment of inflammatory bowel diseases and systemic therapeutics program uses an ingestible capsule for needlefree delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease The company was formerly known as Progenity Inc and changed its name to Biora Therapeutics Inc in April 2022 to reflect its focus on its therapeutics pipeline Biora Therapeutics Inc was founded in 2010 and is headquartered in San Diego California